LANORINAL Drug Patent Profile
✉ Email this page to a colleague
When do Lanorinal patents expire, and when can generic versions of Lanorinal launch?
Lanorinal is a drug marketed by Sandoz and Lannett and is included in two NDAs.
The generic ingredient in LANORINAL is aspirin; butalbital; caffeine. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LANORINAL?
- What are the global sales for LANORINAL?
- What is Average Wholesale Price for LANORINAL?
Summary for LANORINAL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| DailyMed Link: | LANORINAL at DailyMed |
Pharmacology for LANORINAL
US Patents and Regulatory Information for LANORINAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | LANORINAL | aspirin; butalbital; caffeine | CAPSULE;ORAL | 086996-002 | Oct 11, 1985 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lannett | LANORINAL | aspirin; butalbital; caffeine | TABLET;ORAL | 086986-002 | Oct 18, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
